Literature DB >> 22649738

Triple-negative breast cancer.

Quyen D Chu1, Tari King, Thelma Hurd.   

Abstract

Entities:  

Year:  2012        PMID： 22649738      PMCID： PMC3357518          DOI： 10.1155/2012/671684

Source DB:  PubMed          Journal:  Int J Breast Cancer        ISSN： 2090-3189


× No keyword cloud information.
  6 in total

1.  RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.

Authors:  Zahra Shahsavari; Fatemeh Karami-Tehrani; Siamak Salami; Mehran Ghasemzadeh
Journal:  Tumour Biol       Date:  2015-10-26

2.  CD74: a potential novel target for triple-negative breast cancer.

Authors:  Buxian Tian; Yuhong Zhang; Nan Li; Xuewen Liu; Jianfeng Dong
Journal:  Tumour Biol       Date:  2012-08-31

3.  Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage.

Authors:  A Reeder; M Attar; L Nazario; C Bathula; A Zhang; D Hochbaum; E Roy; K L Cooper; S Oesterreich; N E Davidson; C A Neumann; M S Flint
Journal:  Br J Cancer       Date:  2015-04-16       Impact factor: 7.640

4.  Betulinic acid impairs metastasis and reduces immunosuppressive cells in breast cancer models.

Authors:  An-Qi Zeng; Yan Yu; Yu-Qin Yao; Fang-Fang Yang; Mengya Liao; Lin-Jiang Song; Ya-Li Li; Yang Yu; Yu-Jue Li; Yuan-Le Deng; Shu-Ping Yang; Chen-Juan Zeng; Ping Liu; Yong-Mei Xie; Jin-Liang Yang; Yi-Wen Zhang; Ting-Hong Ye; Yu-Quan Wei
Journal:  Oncotarget       Date:  2017-12-17

5.  Hinokiflavone induces apoptosis and inhibits migration of breast cancer cells via EMT signalling pathway.

Authors:  Wenzhen Huang; Chi Liu; Fengen Liu; Zhiyong Liu; Guie Lai; Jian Yi
Journal:  Cell Biochem Funct       Date:  2020-02-27       Impact factor: 3.685

6.  Role of SMC1 in overcoming drug resistance in triple negative breast cancer.

Authors:  Sushma Yadav; Archana Sehrawat; Zeynep Eroglu; George Somlo; Robert Hickey; Sailee Yadav; Xueli Liu; Yogesh C Awasthi; Sanjay Awasthi
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.